<DOC>
	<DOCNO>NCT02342197</DOCNO>
	<brief_summary>Objective : To compare two stimulation protocol , minidose long protocol microdose flare protocol design low responder undergo ICSI . Design : Randomized prospective study . Setting : University hospital IVF unit . Patients : 60 poor responder patient come IVF center ICSI . Interventions : Minidose long protocol half dose agonist administer mid luteal phase day HCG administration compare microdose flare protocol half dose GnRH administer second day cycle day HCG administration . Both group receive Gn stimulation second day cycle ( 300-450 IU ) . Main outcome measure : Number oocytes retrieve .</brief_summary>
	<brief_title>Comparative Study Between Minidose Long Protocol Microdose Flare Protocol Controlled Ovarian Hyperstimulation</brief_title>
	<detailed_description>Patients method : 60 patient expect poor response ovarian stimulation attend kasr EL-Aini hospital IVF center planning ICSI year 2011 randomize receive ovulation induction control ovarian hyperstimulation either one two protocol : Minidose long protocol microdose flare protocol . Inclusion criterion : All patient include classified poor responder one follow criterion present : - Age &gt; 35 year . - Day 3 serum FSH level &gt; 10m IU/ml . - Number antral follicle measure 4-8mm early phase &lt; 6 . - Small ovarian volume . - AMH &lt; 1 . - Prior poor ovarian response COH ( oocytes &lt; 5 ) . Exclusion criterion : - Polycystic ovarian syndrome patient . - Patients Endometriosis . - Normal responder ovulation induction . - Patients ovarian cyst . - Patients receive ovulation induction precede cycle . The study approve Kasr El-Aini IVF center research committee . Each patient give informed consent full explanation procedure . Randomization perform accord computer generate list . The patient randomize two group . The Minidose long protocol : Decapeptyl 50µg/ day administer SC cycle day 21 menstruation . On second day cycle , patient assess downregulation ; E2 level &lt; 50 pg/ml , endometrial thickness le 5 mm , follicles &gt; 15mm . Once patient downregulation confirm , Gn dose commence initial dose 300-450 IU/day first 5 day follow individual adjustment Gn dose accord ovarian response dose Decapeptyl 50µg/day continue day HCG administration . The microdose flare protocol : Administration OCP 's prior menses follow Decapeptyl 50µg/day SC start second day cycle continue day HCG administration . Gn start concomitantly second day cycle describe . Cycle monitoring : Monitoring consist several ultrasound examination serum E2 level protocol . The start Gn dosage determine combination factor include patient age , ovarian reserve testing , prior stimulation response adjust accord individual response . Serum LH level measure day 6 stimulation exclude premature luteinization ( LH &gt; 15 IU/L ) . 10,000 IU HCG administer intramuscular least two leading follicle 18mm diameter . Oocyte retrieval perform 35 hour HCG administration ultrasound guide transvaginal aspiration . Laboratory procedure : The ICSI procedure perform 4 hour oocyte aspiration mature oocytes . Fertilization assess 16-18 hour ICSI consider normal two distinct pronucleus present . The embryo obtain categorized day 2-3 3 grade depend morphological appearance , zonal thickness , cytoplasmic fragmentation blastomere size . Transfer procedure luteal support : Depending patient age , embryo quality number embryo available , 1-4 embryo transfer 2-3 day oocyte collection transabdominal ultrasound guidance use cook catheter . The luteal phase support micronized progesterone 400 mg twice daily administer vaginally pregnancy test perform . Outcome measure : To assess difference pregnancy rate two protocol , sample size 100 's patient consider consider size work , would many year large sample could recruit . We therefore chose focus oocyte number main outcome measure . The data record analysis include : age , infertility history etiology , day 3 FSH , duration stimulation , number gonadotrophin ampoule require , E2 level day HCG administration , number oocyte retrieve fertilized number embryo transfer . The primary outcome measure number oocytes retrieve . The secondary outcome measure implantation clinical pregnancy rate . A clinical pregnancy define normal gestational sac measure transvaginal ultrasound 5 week .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>Age &gt; 35 year Day 3 serum FSH level &gt; 10m IU/ml Number antral follicle measure 48mm early phase &lt; 6 Small ovarian volume AMH &lt; 1 Prior poor ovarian response COH ( oocytes &lt; 5 ) Polycystic ovarian syndrome patient Patients Endometriosis Normal responder ovulation induction Patients ovarian cyst Patients receive ovulation induction precede cycle</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Low responder</keyword>
	<keyword>Minidose long protocol</keyword>
	<keyword>Microdose flare protocol</keyword>
	<keyword>Oocyte yield</keyword>
</DOC>